Terug
Dagbereik
€ 57,00
€ 58,25
52-Weeksbereik
€ 42,52
€ 62,89
Volume
7.768.761
50D / 200D Gem.
€ 58,53
/
€ 50,38
Vorige Slotkoers
€ 57,48
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 16,5 | 0,4 |
| P/B | 6,3 | 2,9 |
| ROE % | 40,5 | 3,7 |
| Net Margin % | 14,6 | 3,8 |
| Rev Growth 5Y % | 1,0 | 10,0 |
| D/E | 2,6 | 0,2 |
Insider Trading Activity
19 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 1, 2026 |
YALE PHYLLIS R
Director
|
grant | 3.996 | € 55,05 | € 219.980 |
| Feb 1, 2026 |
Haller Julia A
Director
|
grant | 3.996 | € 55,05 | € 219.980 |
| Feb 1, 2026 |
Samuels Theodore R. II
Director
|
grant | 3.996 | € 55,05 | € 219.980 |
| Feb 1, 2026 |
Rice Derica W
Director
|
grant | 3.996 | € 55,05 | € 219.980 |
| Dec 31, 2025 |
Rice Derica W
Director
|
grant | 695 | — | — |
| Dec 31, 2025 |
Samuels Theodore R. II
Director
|
grant | 927 | — | — |
| Dec 31, 2025 |
McMullen Michael R.
Director
|
grant | 649 | — | — |
| Oct 2, 2025 |
Gallman Cari
EVP, General Counsel
|
other | 11.448 | — | — |
| Sep 1, 2025 |
Short Bartie Wendy
EVP, Corporate Affairs
|
other | 3.102 | — | — |
| Aug 2, 2025 |
Short Bartie Wendy
EVP, Corporate Affairs
|
other | 1.476 | — | — |
| Aug 2, 2025 |
Short Bartie Wendy
EVP, Corporate Affairs
|
sell | 378 | € 44,23 | € 16.719 |
| Aug 1, 2025 |
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
|
grant | 204.691 | — | — |
| Jun 30, 2025 |
Arduini Peter J
Director
|
grant | 729 | — | — |
| Jun 30, 2025 |
McMullen Michael R.
Director
|
grant | 728 | — | — |
| Jun 3, 2025 |
BOERNER CHRISTOPHER S.
Chief Executive Officer
|
other | 125.440 | — | — |
| Jun 3, 2025 |
Short Bartie Wendy
EVP, Corporate Affairs
|
other | 19.414 | — | — |
| Apr 1, 2025 |
Shanahan Karin
EVP, Glob. Prod. Dev. & Supply
|
other | 8.304 | — | — |
| Mar 31, 2025 |
McMullen Michael R.
Director
|
grant | 512 | € 60,99 | € 31.227 |
| Mar 31, 2025 |
Arduini Peter J
Director
|
grant | 553 | € 60,99 | € 33.727 |
Belangrijkste Punten
Revenue grew 0,96% annually over 5 years — modest growth
ROE of 40,53% indicates high profitability
Debt/Equity of 2,55 — high leverage
Generating 12,85B in free cash flow
Cash machine — converts 182,12% of earnings into free cash flow
Capital efficient — spends only 2,72% of revenue on capex
Groei
Revenue Growth (5Y)
0,96%
Revenue (1Y)-0,22%
Earnings (1Y)N/A
FCF Growth (3Y)0,76%
Kwaliteit
Return on Equity
40,53%
ROIC14,51%
Net Margin14,63%
Op. Margin26,34%
Veiligheid
Debt / Equity
2,55
Current Ratio1,26
Interest Coverage8,41
Waardering
P/E Ratio
16,46
P/B Ratio6,28
EV/EBITDA12,05
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,22% | Revenue Growth (3Y) | 3,48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -6,25% |
| Revenue Growth (5Y) | 0,96% | Earnings Growth (5Y) | 0,21% |
| Profitability | |||
| Revenue (TTM) | 48,19B | Net Income (TTM) | 7,05B |
| ROE | 40,53% | ROA | 7,83% |
| Gross Margin | 67,65% | Operating Margin | 26,34% |
| Net Margin | 14,63% | Free Cash Flow (TTM) | 12,85B |
| ROIC | 14,51% | FCF Growth (3Y) | 0,76% |
| Safety | |||
| Debt / Equity | 2,55 | Current Ratio | 1,26 |
| Interest Coverage | 8,41 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 16,46 | P/B Ratio | 6,28 |
| P/S Ratio | 2,41 | PEG Ratio | -0,09 |
| EV/EBITDA | 12,05 | Dividend Yield | 0,05% |
| Market Cap | 116,08B | Enterprise Value | 153,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 48,19B | 48,30B | 45,01B | 46,16B | 46,39B |
| Net Income | 7,05B | -8,95B | 8,03B | 6,33B | 6,99B |
| EPS (Diluted) | 3,45 | -4,41 | 3,86 | 2,95 | 3,12 |
| Gross Profit | 32,60B | 27,43B | 25,36B | 26,49B | 26,76B |
| Operating Income | 12,70B | 9,66B | 8,47B | 9,27B | 9,54B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90,04B | 92,60B | 95,16B | 96,82B | 109,31B |
| Total Liabilities | 71,53B | 76,22B | 65,67B | 65,70B | 73,31B |
| Shareholders' Equity | 18,47B | 16,34B | 29,43B | 31,06B | 35,95B |
| Total Debt | 47,14B | 51,20B | 41,46B | 40,72B | 45,60B |
| Cash & Equivalents | 10,21B | 10,35B | 11,46B | 9,12B | 13,98B |
| Current Assets | 29,39B | 29,78B | 31,77B | 27,27B | 33,26B |
| Current Liabilities | 23,42B | 23,77B | 22,26B | 21,89B | 21,87B |